Sagimet Biosciences Inc. SGMT
9.12 USD -0.87 (-8.71%)
At closeNov 6, 2026, 5:24 AM EST
9.00 -0.12 -1.32%
Pre-market · Nov 6, 5:24 AM ET
9.06 Day range 9.95
4.50 52-week range 11.45
- YTD
- +54.05%
- 1 year
- +18.60%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -56.89M | -54.45M | -30.74M | -31.05M | -23.72M | |
| -51.04M | -45.57M | -27.88M | -30.50M | -24.44M | |
| -1.58 | -1.45 | -2.66 | -165.20 | -199.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 35.02M | 75.84M | 75.14M | 185.00K | 56.76M | |
| 116.48M | 160.26M | 96.72M | 33.03M | 59.03M | |
| 5.10M | 4.45M | 5.65M | 5.36M | 2.67M | |
| 78.00K | 78.00K | 65.00K | 211.00K | 348.00K | |
| 111.38M | 155.81M | 91.06M | -186.95M | -158.26M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -45.65M | -42.44M | -23.77M | -24.49M | -21.71M | |
| 4.56M | -61.68M | 12.58M | -32.01M | 0 | |
| 275.00K | 104.82M | 86.17M | -73.00K | 9.74M | |
| -40.82M | 701.00K | 74.98M | -56.57M | -11.97M |